FMS:NYE-Fresenius Medical Care Corporation (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 24.35

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.22M

Analyst Target

USD 44.77
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-09 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

N/A

USD 78.64B
DVA DaVita HealthCare Partners Inc

N/A

USD 13.64B
THC Tenet Healthcare Corporation

N/A

USD 13.36B
UHS Universal Health Services Inc

N/A

USD 12.40B
EHC Encompass Health Corp

N/A

USD 10.06B
CHE Chemed Corp

N/A

USD 8.24B
CON Concentra Group Holdings Paren..

N/A

USD 2.93B
ARDT Ardent Health Partners, Inc.

N/A

USD 2.59B
NHC National HealthCare Corporatio..

N/A

USD 1.90B
AGL agilon health Inc

N/A

USD 1.27B

ETFs Containing FMS

UTES Virtus Reaves Utilities E.. 4.72 % 0.95 %

N/A

USD 0.37B
RYU 3.37 % 0.40 %

N/A

N/A
CDC VictoryShares US EQ Incom.. 1.50 % 0.35 %

N/A

USD 0.78B
CDL VictoryShares US Large Ca.. 1.46 % 0.35 %

N/A

USD 0.35B
LKOR FlexShares Credit-Scored .. 0.37 % 0.22 %

N/A

USD 0.04B
JPGL:LSE JPM Global Equity Multi-F.. 0.31 % 0.00 %

N/A

USD 0.17B
TPYP Tortoise North American P.. 0.00 % 0.40 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.55% 68% D+ 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.55% 68% D+ 85% B
Trailing 12 Months  
Capital Gain 24.62% 70% C- 81% B-
Dividend Return 3.24% 80% B- 49% F
Total Return 27.86% 70% C- 82% B
Trailing 5 Years  
Capital Gain -39.71% 22% F 13% F
Dividend Return 8.67% 88% B+ 26% F
Total Return -31.04% 28% F 12% F
Average Annual (5 Year Horizon)  
Capital Gain -13.09% 13% F 4% F
Dividend Return -10.59% 13% F 5% F
Total Return 2.50% 90% A- 56% F
Risk Return Profile  
Volatility (Standard Deviation) 26.79% 87% B+ 40% F
Risk Adjusted Return -39.54% 13% F 6% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector